Document Detail


Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle.
MedLine Citation:
PMID:  18759853     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. The present review discusses the potential role of nitric oxide (NO) in the: (i) regulation of skeletal muscle glucose uptake during exercise; and (ii) activation of mitochondrial biogenesis after exercise. 2. We have shown in humans that local infusion of an NO synthase inhibitor during exercise attenuates increases in skeletal muscle glucose uptake without affecting blood flow. Recent studies from our laboratory in rodents support these findings in humans, although rodent studies from other laboratories have yielded conflicting results. 3. There is clear evidence that NO increases mitochondrial biogenesis in non-contracting cells and that NO influences basal skeletal muscle mitochondrial biogenesis. However, there have been few studies examining the potential role of NO in the activation of mitochondrial biogenesis following an acute bout of exercise or in response to exercise training. Early indications are that NO is not involved in regulating the increase in mitochondrial biogenesis that occurs in response to exercise. 4. Exercise is considered the best prevention and treatment option for diabetes, but unfortunately many people with diabetes do not or cannot exercise regularly. Alternative therapies are therefore critical to effectively manage diabetes. If skeletal muscle NO is found to play an important role in regulating glucose uptake and/or mitochondrial biogenesis, pharmaceutical agents designed to mimic these effects of exercise may improve glycaemic control.
Authors:
Glenn K McConell; Glenn D Wadley
Related Documents :
19522753 - Electromyographic activity in lower limb muscles is temporally associated with the slow...
10490803 - Skeletal muscle ucp2 and ucp3 expression in trained and untrained male subjects.
15650833 - Effects of home-based daily exercise therapy on joint mobility, daily activity, pain, a...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2008-08-26
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  35     ISSN:  1440-1681     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-11-05     Completed Date:  2009-05-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  1488-92     Citation Subset:  IM    
Affiliation:
Department of Physiology, The University of Melbourne, Melbourne, Victoria, Australia. mcconell@unimelb.edu.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Glucose / metabolism*
Humans
Mitochondria / metabolism*
Muscle Contraction / physiology*
Muscle, Skeletal / metabolism*
Nitric Oxide / physiology*
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice.
Next Document:  Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch...